SAN FRANCISCO--(BUSINESS WIRE)--Javelin Venture Partners announced today new investors in Javelin Venture Partners V with $125 million primary and associated funds dedicated to investing in technology ...
Says prior data had inconsistencies due to external vendor Says plans to meet with FDA to discuss path for pain drug Shares up about 6 pct Feb 11 (Reuters) - Javelin Pharmaceuticals Inc Thursday said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results